ASK
THE DOCTOR: Meningitis vaccine daughter's decision
By DR. JIM MITTERANDO
The Patriot Ledger
Q.
My daughter is going to college this fall and she received a letter
from her college advising her to consider receiving the meningitis vaccine.
What do you recommend?
A.
An outbreak of meningococcal meniningits that killed two teenagers
in Ohio two weeks ago, has shone a spotlight on bacterial meningitis,
a rare but contagious and potentially lethal disease.
Meningitis,
an infection and inflammation of the membranes and fluid surrounding
the brain and spinal cord, causes severe headaches, high fever, sensitivity
to light and a stiff neck.
Most cases are viral, and neither contagious nor life-threatening. Viral
meningitis typically occurs in the summertime and particularly affects
young children.
Whereas
the bacterial form of the disease requires intravenous antibiotic therapy,
viral meningitis resolves without treatment.
It
is important to diagnose and treat bacterial meningitis early to prevent
brain damage or death. Diagnosis usually is made by growing bacteria
from a sample of spinal fluid.
Distinguishing
viral from bacterial meningitis requires a procedure called a spinal
tap, which involves inserting a needle between the vertebrae in the
lower back and collecting spinal fluid.
Meningococcal
meningitis, a form of bacterial meningitis, mostly affects children
and kills rapidly in about 10 percent of cases. It is rare, affecting
1 in every 100,000 people. There have been no recent epidemics of meningococcal
meningitis in New England. The heightened news coverage of meningitis
gives the illusion that this disease occurs commonly.
People
who come in close contact with someone who has meningococcal meningitis
can protect themselves with a prophylactic antibiotic prescribed by
their doctor. I often hear from patients worried about exposure to "meningitis,"
but usually it turns out to be noncontagious viral meningitis, which
does not require preventive treatment.
As
a precaution, state and federal officials opted to vaccinate students
and faculty members living in or near the Ohio town in which the two
teenagers died. Routine immunization is not recommended for the general
population, though, because of the rarity of meningococcal meningitis.
The
American Academy of Pediatrics, the CDC and many colleges recommend
incoming freshmen consider receiving the meningococcal vaccine, because
among students living in dormitories the rate of infection quadruples,
from 1 in every 100,000 people to 4 in every 100,000 people.
But
70 percent of cases of meningococcal meningitis occur in children younger
than 5; unfortunately, though, the vaccine is ineffective in young children.
Generally,
because of the rarity of the disease, I leave the vaccination decision
to the student. I explain that 30,000 students would have to be vaccinated
to prevent one case of meningococcal meningitis and 300,000 students
would need to be vaccinated to prevent one death from this illness.
But if the disease worries you or your daughter, I recommend vaccination,
if only for peace of mind.
Most
health insurance companies pay for the meningococcal vaccine for college-age
students. The vaccine, which costs around $75 and may protect against
infection for only five years, is safe and produces no significant side
effects.
People
traveling to certain high-risk countries in Africa and Asia may want
to consider the vaccine, because meningococcal meningitis may be more
common there.
Dr.
Jim Mitterando is a family doctor at Health Care South/Cohasset Family
Practice and a staff member at South Shore Hospital in Weymouth.
Readers
should send questions to: Ask the Doctor, The Patriot Ledger, P.O. Box
699159, Quincy, MA 02269-9159, or by E-mail to his attention at features@ledger.com.
Questions
of general interest will be answered in this column. The information
in this column is not intended to diagnose individual conditions, and
individual replies are not possible. Readers should see their own doctors
about specific problems.
Copyright
2001 The Patriot Ledger
Transmitted June 12, 2001